Contract HHSO100201600029C
Modernatx, Inc. · Department Of Health And Human Services · September 1, 2016
Modernatx, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 1, 2016 for $72.97 million of work in research and development in biotechnology. Performance is in Cambridge, MA. It was awarded under full and open competition. The contract has been modified 12 times since the base award It uses cost-plus contract pricing. The most recent modification was on September 5, 2024.
Contract details
- PIID
- HHSO100201600029C
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Cambridge, MA
- First action
- September 1, 2016
- Latest action
- September 5, 2024
Description
THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE FUNDING IN THE AMOUNT OF $6,336.92 IN CANCELLING FUNDS FROM CLIN 0001.
Modification timeline
-
September 5, 2024Mod P00012$-6.3K
-
June 6, 2023Mod P00011THIS NO COST MODIFICATION IS TO CHANGE THE PERIOD OF PERFORMANCE FROM 09/01/2016 TO 07/01/2024. THE CURRENT NCE IS FOR AN ADDITIONAL 6 MONTHS FROM THE PREVIOUS$0
-
April 17, 2023Mod P00010THIS NO COST MODIFICATION IS TO CHANGE THE CONTRACTING OFFICER FROM JONATHAN GONZALEZ TO ERIN GRENINGER. ACCORDINGLY, UNDER SECTION G.1. CONTRACTING OFFICER, DE$0
-
September 22, 2022Mod P00009THIS MODIFICATION IS TO DE-OBLIGATE THE AMOUNT OF $36,249,104.41 OF FUNDING WHICH WILL OTHERWISE EXPIRE$-36.25M
-
September 14, 2022Mod P00008TO CHANGE POP END AND ADD NEW SOW$0
-
June 7, 2021Mod P00007MODERNA THERAPEUTICS, INC:ADVANCE THE DEVELOPMENT OF AN MRNA VACCINE FOR THE PREVENTION OF ZIKA VIRUS$-8.10M
-
August 27, 2020Mod P00006MODERNA THERAPEUTICS, INC:ADVANCE THE DEVELOPMENT OF AN MRNA VACCINE FOR THE PREVENTION OF ZIKA VIRUS$0
-
August 10, 2018Mod 5MODERNA THERAPEUTICS, INC:ADVANCE THE DEVELOPMENT OF AN MRNA VACCINE FOR THE PREVENTION OF ZIKA VIRUS:: IGF::OT::IGF$0
-
December 27, 2017Mod 4MODERNA THERAPEUTICS, INC:ADVANCE THE DEVELOPMENT OF AN MRNA VACCINE FOR THE PREVENTION OF ZIKA VIRUS:: IGF::OT::IGF$0
-
March 20, 2017Mod 2MODERNA THERAPEUTICS, INC:ADVANCE THE DEVELOPMENT OF AN MRNA VACCINE FOR THE PREVENTION OF ZIKA VIRUS:: IGF::OT::IGF$64.91M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201600029C?
Contract HHSO100201600029C is a federal contract awarded to Modernatx, Inc. by Department Of Health And Human Services on September 1, 2016 for $72.97 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 12 times since the base award.
Who won contract HHSO100201600029C?
Modernatx, Inc. won contract HHSO100201600029C from Department Of Health And Human Services.
How much is contract HHSO100201600029C worth?
Contract HHSO100201600029C has obligated $72.97 million to date, with a total potential value of $81.40 million if all options are exercised.